1 January 2025 false No description of principal activity Taxfiler 2024.6 05169215business:PrivateLimitedCompanyLtd2025-01-012025-12-31 051692152024-12-31 051692152025-01-012025-12-31 05169215business:AuditExempt-NoAccountantsReport2025-01-012025-12-31 05169215business:FilletedAccounts2025-01-012025-12-31 051692152025-12-31 05169215business:Director12025-01-012025-12-31 05169215business:Director22025-01-012025-12-31 05169215business:RegisteredOffice2025-01-012025-12-31 051692152024-12-31 05169215core:WithinOneYear2025-12-31 05169215core:WithinOneYear2024-12-31 05169215core:ShareCapitalcore:PreviouslyStatedAmount2025-12-31 05169215core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 05169215core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-12-31 05169215core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 05169215core:PreviouslyStatedAmount2025-12-31 05169215core:PreviouslyStatedAmount2024-12-31 05169215business:SmallEntities2025-01-012025-12-31 05169215countries:EnglandWales2025-01-012025-12-31 05169215core:PlantMachinery2025-01-012025-12-31 05169215core:PlantMachinery2024-12-31 05169215core:PlantMachinery2025-12-31 05169215core:AfterOneYear2025-12-31 05169215core:AfterOneYear2024-12-31 051692152024-01-012024-12-31 iso4217:GBP xbrli:pure
Company Registration No. 05169215 (England and Wales)
COVISION MEDICAL TECHNOLOGIES LIMITED Unaudited accounts for the year ended 31 December 2025
COVISION MEDICAL TECHNOLOGIES LIMITED Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
COVISION MEDICAL TECHNOLOGIES LIMITED Company Information for the year ended 31 December 2025
Directors
DAYIBASI, Ugur OZKAN, Mehmet
Company Number
05169215 (England and Wales)
Registered Office
84 Brook Street Office 4.3 London London W1K 5EH England
- 3 -
COVISION MEDICAL TECHNOLOGIES LIMITED Statement of financial position as at 31 December 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Investments
5
584,503 
584,503 
Current assets
Debtors
6
95,720 
544,218 
Cash at bank and in hand
34,698 
18,052 
130,418 
562,270 
Creditors: amounts falling due within one year
7
470,869 
35,091 
Net current assets
601,287 
597,361 
Net assets
1,185,790 
1,181,864 
Capital and reserves
Called up share capital
1,500,000 
1,500,000 
Profit and loss account
(314,210)
(318,136)
Shareholders' funds
1,185,790 
1,181,864 
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 2 September 2026 and were signed on its behalf by
DAYIBASI, Ugur Director Company Registration No. 05169215
- 4 -
COVISION MEDICAL TECHNOLOGIES LIMITED Notes to the Accounts for the year ended 31 December 2025
1
Statutory information
COVISION MEDICAL TECHNOLOGIES LIMITED is a private company, limited by shares, registered in England and Wales, registration number 05169215. The registered office is 84 Brook Street, Office 4.3, London, London, W1K 5EH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Investments
Investments in subsidiaries are measured at cost less accumulated impairment.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25%
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 January 2025
29,422 
At 31 December 2025
29,422 
Depreciation
At 1 January 2025
29,422 
At 31 December 2025
29,422 
Net book value
At 31 December 2025
- 
- 5 -
COVISION MEDICAL TECHNOLOGIES LIMITED Notes to the Accounts for the year ended 31 December 2025
5
Investments
Subsidiary undertakings 
£ 
Valuation at 1 January 2025
584,503 
Valuation at 31 December 2025
584,503 
The company holds 100% of the ordinary share capital of Covision Medical Technologies Sanayi, a company registered in Turkey. The company has taken the exemption from preparing consolidated financial statements as applicable under the small companies regime.
6
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
1,769 
2,145 
Trade debtors
(62,036)
386,088 
Other debtors
- 
4 
(60,267)
388,237 
Amounts falling due after more than one year
Amounts due from group undertakings etc.
154,981 
154,981 
Other debtors
1,006 
1,000 
155,987 
155,981 
7
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
(470,878)
(35,100)
Other creditors
9 
9 
(470,869)
(35,091)
8
Average number of employees
During the year the average number of employees was 2 (2024: 2).
- 6 -